Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Elpazhina
- Development stage
- Unknown
- Lead developer
- Espad Pharmed
- Administration
- Subcutaneous, Intradermal
01
Overview
Elpazhina is a hyaluronic acid-based dermal filler developed and manufactured by Espad Pharmed. It is designed for aesthetic and cosmetic applications, specifically for soft-tissue augmentation, the correction of facial wrinkles, and facial volumization. As a hyaluronic acid filler, it works by physically occupying space in the dermal or subcutaneous layers of the skin and attracting water molecules to restore lost volume and smooth out facial lines. It is administered via dermal, subcutaneous, or intracutaneous injection and is part of a broader portfolio of aesthetic injectables produced by the company.
- Brand names
- Elpazhina
Beyond the preview
Go deeper on Elpazhina.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elpazhina.